Efficacy and Safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Sentinel Sites across Côte d'Ivoire

Malaria Research and Treatment
William YavoEby Ignace Hervé Menan

Abstract

Two years after the introduction of free Artesunate-Amodiaquine (ASAQ) and Artemether-Lumefantrine (AL) for the treatment of uncomplicated malaria in public health facilities in Côte d'Ivoire, we carried out this study to compare their efficacy and tolerability in three surveillance sites. It was a multicentre open randomised clinical trial of 3-day ASAQ treatment against AL for the treatment of 2 parallel groups of patients aged 2 years and above. The endpoints were (1) Adequate Clinical and Parasitological Response (ACPR) at day 28 and (2) the clinical and biological tolerability. Of the 300 patients who were enrolled 289, with 143 (49.5%) and 146 (50.5%) in the ASAQ and AL groups, respectively, correctly followed the WHO 2003 protocol we used. The PCR-corrected ACPR was 99.3% for each group. More than 94% of patients no longer showed signs of fever, 48 hours after treatment. Approximately 78% of the people in the ASAQ group had a parasite clearance time of 48 hours or less compared to 81% in the AL group (p = 0.496). Both drugs were found to be well tolerated by the patients. This study demonstrates the effectiveness and tolerability of ASAQ and AL supporting their continuous use for the treatment of uncomplicated P. falcipa...Continue Reading

References

Mar 21, 1998·The American Journal of Tropical Medicine and Hygiene·R E PaulK P Day
Jan 2, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·M van VugtF Nosten
Jul 21, 2004·Lancet·Peter Gottfried Kremsner, Sanjeev Krishna
Sep 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andreas MårtenssonAnders Björkman
Jul 28, 2006·PLoS Clinical Trials·Hasifa BukirwaSarah G Staedke
Nov 9, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Issaka ZongoJean Bosco Ouédraogo
Dec 10, 2008·The New England Journal of Medicine·Harald NoedlUNKNOWN Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium
Dec 17, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·Christopher V Plowe
Oct 14, 2011·The New England Journal of Medicine·Arjen M DondorpChristopher V Plowe
Aug 3, 2012·The American Journal of Tropical Medicine and Hygiene·Rick M FairhurstArjen M Dondorp

❮ Previous
Next ❯

Citations

Apr 26, 2016·Journal of Parasitology Research·William YavoMarielle K Bouyou-Akotet
Jul 28, 2017·The American Journal of Tropical Medicine and Hygiene·Benjamin K AbuakuAnita Ghansah
Aug 30, 2019·Tropical Medicine & International Health : TM & IH·Catherine Olufunke FaladeDaniel Chandramohan

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
PCR

Software Mentioned

SPSS
Epi

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2021 Meta ULC. All rights reserved